Concepedia

Author

Yingqi Hua

Shanghai First People's HospitalORCID

Also Known As

Hua Yingqi, Hua, Y., P Koty, Y Hua, Y Q Hua, Y. HUA, Y. Hua, YING-QI HUA, YINGQI HUA, Yantang Hua

162

Publications

7.3K

Citations

38

H-Index

111

Concepts

All Affiliations

Shanghai First People's HospitalShanghai Jiao Tong UniversityShanghai Tenth People's HospitalTongji UniversityUniversity of Michigan
YH

About

Yingqi Hua is an author at Shanghai First People's Hospital specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

28

1.3K

2

Health Sciences

6

6

270

3

Engineering

4

4

239

4

Public Health

1

1

16

5

Applied Physics

1

1

83

Yingqi Hua

×

68

Publications

5.7K

Citations

32

H-Index

YearCitations

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>

Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah,

Autophagy

2021

2.5K

Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo

Hui Wang, Tie‐Ning Zhang, Weijie Sun,

Cell Death and Disease

2016

225

The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis

Zeze Fu, Biyong Deng, Yuxin Liao,

BMC Cancer

2013

175

Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma

Gangyang Wang, Tao Zhang, Wei Sun,

Free Radical Biology and Medicine

2017

151

Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis

Suoyuan Li, Tao Zhang, Weiguo Xu,

Theranostics

2018

148

Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis <i>via</i> dual blockade of VEGFR2 and MET in osteosarcoma

Gangyang Wang, Mengxiong Sun, Yafei Jiang,

International Journal of Cancer

2019

142

Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3

Tie‐Ning Zhang, Jingyang Li, Fang Yin,

Oncogene

2017

140

Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation

Zifei Zhou, Tuan‐Wei Sun, Feng Chen,

Biomaterials

2016

114

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment

Yafei Jiang, Jinzeng Wang, Mengxiong Sun,

Nature Communications

2022

110

CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma

Zongyi Wang, Fei Yin, Jing Xu,

Journal of Experimental & Clinical Cancer Research

2019

109

Page 1